Diltiazem Hydrochloride Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Jan 5, 2026 · last update Jan 5, 2026
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jan 5, 2026 Updated Jan 5, 2026 Discontinued Jan 5, 2026 |